Company Filing History:
3 out of 3,446 
2 out of 1,552 
Years Active: 2009-2014
Title: Innovations by Linda Stevens in Pulmonary Disease Treatment
Introduction
Linda Stevens is a notable inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of pulmonary disease treatment, holding a total of 3 patents. Her work focuses on innovative methods for treating pulmonary conditions and enhancing protein production.
Latest Patents
Among her latest patents, Stevens has developed a method for the treatment of pulmonary disease. This method involves administering a therapeutically effective amount of a polypeptide that includes at least one arginine residue susceptible to ADP-ribosylation and nicotinamide adenine dinucleotide (NAD). In some cases, the polypeptide and/or NAD is administered via inhalation. Additionally, she has disclosed a pharmaceutical composition that includes at least one polypeptide, such as HNP-1, and NAD. Another significant patent involves a method for producing a polypeptide with modified activity by replacing an arginine residue with tryptophan or phenylalanine. This innovation aims to enhance the stability and efficacy of therapeutic proteins.
Career Highlights
Linda Stevens has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Massachusetts. Her experience in these institutions has allowed her to contribute to groundbreaking research and development in her field.
Collaborations
Stevens has collaborated with notable colleagues, including Joel Moss and Christelle Bourgeois. These partnerships have further enriched her research and innovation efforts.
Conclusion
Linda Stevens is a pioneering inventor whose work in pulmonary disease treatment has the potential to significantly impact patient care. Her innovative methods and collaborations highlight her commitment to advancing medical science.